Found: 7
Select item for more details and to access through your institution.
Cholinesterase Inhibitors for Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 18, p. 2359, doi. 10.1001/jama.289.18.2359-a
- By:
- Publication type:
- Article
APOE Genotype: No Influence on Galantamine Treatment Efficacy Nor on Rate of Decline in Alzheimer's Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2001, v. 12, n. 2, p. 69, doi. 10.1159/000051238
- By:
- Publication type:
- Article
Galantamine: Additional Benefits to Patients with Alzheimer's Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2000, v. 11, p. 19, doi. 10.1159/000051228
- By:
- Publication type:
- Article
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The Authors Reply.
- Published in:
- 2003
- By:
- Publication type:
- Letter
A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease.
- Published in:
- Drugs & Aging, 2003, v. 20, n. 10, p. 777, doi. 10.2165/00002512-200320100-00006
- By:
- Publication type:
- Article
Comparative Effectiveness Research in the Regulatory Setting.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 5, doi. 10.1007/BF03256887
- By:
- Publication type:
- Article